** Shares of health insurer Cigna CI.N rise 1.7% to $340.70 premarket
** Co raises full-year earnings forecast and beats estimates for quarterly profit on strong performance in its pharmacy benefit management business and lower-than-expected medical costs in its insurance arm
** Co forecasts 2025 adj. profit of at least $29.60 per share vs previous estimate of $29.50 and analysts' estimate of $29.61, as per data compiled by LSEG
** Co reports Q1 adj. income from operations of $6.74, above estimates of $6.35
** Co's Q1 medical care ratio - the percentage of premiums spent on medical care, came in at 82.2%, lower than analysts' estimates of 82.63%
** "At first glance, Cigna rebounded from a challenging Q4 to post a strong Q1 beat. Although the guidance raise was modest relative to the beat, this could reflect some early-year conservatism"- brokerage Oppenheimer
** Up to last close, stock was up 21.4% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。